Phase I/II Evaluation Temozolomide and Farnesyl Transferase Inhibitor ZARNESTRA (R115777) for the Treatment of Recurrent and Progressive Glioblastoma Multiforme.
Phase of Trial: Phase I/II
Latest Information Update: 31 Jul 2012
At a glance
- Drugs Temozolomide; Tipifarnib
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 14 Jul 2009 Status changed from suspended to completed as reported by ClinicalTrials.gov.
- 14 Sep 2005 New trial record.